oncology Chronic Graft-versus-host Disease: Expert Interview Dr. Dennis Kim — Length: 07:00 Clinical Application of Extracorporeal Photopheresis for Treatment of Chronic Graft-versus-host Disease Watch Presentation
Hematology European Hematology Association (EHA) 2023 Hybrid Congress June 8-11, 2023 — Frankfurt, Germany Long-term Efficacy in CLL: Expanding Evidence Across Treatment-naïve and Relapsed/Refractory Patients Download 3 PowerPoint slides
Hematology European Hematology Association (EHA) 2023 Congress: Expert Interview Dr. Talha Munir — Length: 04:16 SEQUOIA Extended Follow-up: Reinforced Front-Line Effectiveness of Second-Generation BTK Inhibitor Watch Presentation
Hematology American Society of Clinical Oncology (ASCO) 2023 Annual Meeting June 2-6, 2023 — Chicago, Illinois BTK Inhibitors Differentiated on Safety and Efficacy in CLL Download 4 PowerPoint slides
Hematology Allogeneic Stem Cell Transplantation: Expert Review and Commentary Dr. Mattias Stelljes, Dr. Thomas J. Nevill & Dr. Victor Lewis Conditioning for Allogeneic Hematopoietic Stem Cell: Strategies Compared Download 2 PowerPoint slides
Hematology Waldenström Macroglobulinemia: Expert Interview Dr. Laurie H Sehn — Length: 06:19 A Canadian Perspective on the Role of BTK Inhibitors in the Treatment of WM Watch Presentation
Hematology 64th American Society of Hematology (ASH) Annual Meeting: Expert Interview Dr. Carolyn Owen — Length: 05:00 ALPINE Trial Demonstrates Superior Response of Second-Generation BTK Inhibitor in CLL/SLL Watch Presentation
Hematology 64th American Society of Hematology (ASH) Annual Meeting and Exposition December 10-13, 2022 — New Orleans, Louisiana ALPINE Head-to-head Trial, Second-generation BTK Inhibitor Shown to be More Effective and Safer in CLL Download 4 PowerPoint slides
Hematology 64th American Society of Hematology (ASH) Annual Meeting: Expert Interview Dr. Dennis Kim — Length: 05:18 STAMP Inhibitor Broadens the Treatment Landscape in Chronic Myeloid Leukemia Watch Presentation
Hematology 64th American Society of Hematology (ASH) Annual Meeting and Exposition December 10-13, 2022 — New Orleans, Louisiana Novel Small Molecule Inhibitor Broadens the Treatment Landscape in Chronic Myeloid Leukemia Download 4 PowerPoint slides
Hematology 64th American Society of Hematology (ASH) Annual Meeting: Expert Interview Dr. Laurie H. Sehn — Length: 05:00 New Data Shifts Risk-benefit of BTK Inhibitors in CLL/SLL Watch Presentation
oncology European Society of Medical Oncology (ESMO) 2022: Expert Interview Dr. Karen Gelmon — Length: 05:26 Reviewing Overall Survival from Large Multicenter Trials: CDK4/6 Inhibitors for Advanced Breast Cancer Watch Presentation